SiliconInvestor
     Advanced Search   [ sign in ]

register
Register

 Biotech / Medical : biotech firesales

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: tom pope who wrote (2548)3/22/2010 2:25:20 PM
From: tuckRead Replies (3) of 3042
 
CTIC off something like 45% on negative panel vote for Pixantrone. A shame. Had CTIC devoted the resources, they might have run & recruited a proper trial. Pixantrone seemed to definitely have more potential than Opaxio after the latter failed it first P3.

Price action all over the map, so who knows where this will close.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.